Acta Psychiatrica Scandinavica

Cover image for Acta Psychiatrica Scandinavica

September 1990

Volume 82, Issue S360

Pages 5–110

  1. Preface

    1. Top of page
    2. Preface
    3. Original Article
    1. Preface (pages 5–6)

      J. Angst

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05316.x

  2. Original Article

    1. Top of page
    2. Preface
    3. Original Article
    1. Some basic aspects of reversible inhibitors of monoamine oxidase-A (pages 7–12)

      M. Da Prada, R. Kettler, W. P. Burkard, H. P. Lorez and W. Haefely

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05317.x

    2. Antidepressants, alcohol and psychomotor performance (pages 13–17)

      J. W. G. Tiller

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05318.x

    3. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders (pages 29–34)

      M. R. Liebowitz, E. Hollander, F. Schneier, R. Campeas, L. Welkowitz, J. Hatterer and B. Fallon

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05321.x

    4. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium (page 42)

      L. Botte, C. Gilles, J. L. Evrard, P. Mesters, C. Wolfram, M. Berger, K. Hellstern and J. Ward

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05323.x

    5. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression (page 43)

      M. Casacchia and E. Moll

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05324.x

    6. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany (pages 46–47)

      H. J. Funke, E. Moritz, K. Hellstern and H. Malanowski

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05326.x

    7. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain (pages 48–49)

      J. Civeira, S. Cervera, J. Giner, S. R. Allen, K. Hellstern, H. Malanowski, R. Wirz and K. Klär

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05327.x

    8. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium (pages 50–51)

      M. Dierick, P. Cattiez, G. Franck, P. Burton, J. Defleur, W. Hermans, A. Roelandts, C. Wolfram, M. Berger, K. Hellstern and J. Ward

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05328.x

    9. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium (pages 52–53)

      G. Beckers, A. Vereecken, E. de Bleeker, C. Jaunes, G. Sieben, J. Faidherbe, C. Wolfram, M. Berger, K. Hellstern and J. Ward

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05329.x

    10. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients (pages 54–56)

      R. Ucha Udabe, C. A. Márquez, C. A. Traballi and N. Portes

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05330.x

    11. Moclobemide, imipramine and placebo in the treatment of major depression (pages 57–58)

      M. Versiani, A. E. Nardi, F. D. Mundim, A. Alves and W. Schmid-Burgk

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05331.x

    12. Moclobemide versus tranylcypromine in the treatment of depression (pages 61–62)

      L. Rossel and E. Mell

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05333.x

    13. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression (page 63)

      I. Gabelic and B. Kuhn

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05334.x

    14. Moclobemide compared with second-generation antidepressants in elderly people (pages 64–66)

      M. De Vanna, J. Kummer, A. Agnoli, P. Gentili, A. Lorizio and R. Anand

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05335.x

    15. Moclobemide (Ro 11-1163) in long-term treatment (pages 67–68)

      C. N. Stefanis and K. Merz-Frei

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05336.x

    16. Moclobemide (Ro 11-1163) safety in depressed patients (pages 69–70)

      E. Moll and W. Hetzel

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05337.x

    17. Effects of moclobemide on sleep in healthy human subjects (pages 73–75)

      R. Blois and J. M. Gaillard

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05339.x

    18. Interaction between orally administered tyramine and moclobemide (pages 78–80)

      R. Zimmer, A. J. Puech, F. Philipp and A. Korn

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05341.x

    19. Interaction studies with moclobemide (pages 84–86)

      R. Zimmer, R. Gieschke, R. Fischbach and S. Basic

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05343.x

    20. Biotransformation of moclobemide in humans (pages 87–90)

      R. Jauch, E. Griesser, G. Oesterhelt, W. Arnold, W. Melster, W. H. Ziegler and T. W. Guentert

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05344.x

    21. Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 days (pages 91–93)

      T. W. Guentert, G. Tucker, A. Korn, J. P. Pfefen, P. Haefelfinger and M. P. Schoerlin

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05345.x

    22. Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function (pages 94–97)

      K. Stoeckel, J. P. Pfefen, M. Mayersohn, M. P. Schoerlin, C. Andressen, E. E. Ohnhaus, F. Frey and T. W. Guentert

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05346.x

    23. Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquine (pages 98–100)

      M. P. Schoerlin, R. A. Blouin, J. P. Pfefen and T. W. Guentert

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05347.x

    24. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats (pages 101–102)

      R. Kettler, M. Da Prada and W. P. Burkard

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05348.x

    25. Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemide (pages 103–105)

      M. Da Prada, R. Kettler, H. H. Keller and W. P. Burkard

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05349.x

    26. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats (pages 106–107)

      M. Da Prada and W. P. Burkard

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05350.x

SEARCH

SEARCH BY CITATION